Related by context. All words. (Click for frequent words.) 81 Prolongs Survival 79 Demonstrates Potent 78 Drug Candidate 78 Receives Orphan Drug Designation 78 Demonstrates Significant 78 Combination Treatment 78 Initiates Clinical Trial 78 Meets Primary Endpoint 78 Presents Preclinical Data 78 Single Dose 77 Initiates Clinical 77 Phase 2b Trial 77 Chronic Hepatitis C 77 Study Evaluating 77 Initiate Phase 77 Anti Tumor 77 Integrase Inhibitor 77 Phase 2b Clinical Trial 77 Phase IIa Clinical Trial 77 Clinical Trial Results 77 Phase IIb Trial 77 Lupus Drug 77 Phase III Clinical Trial 77 Treatment Naïve 77 Completes Patient Enrollment 76 Combination Therapy 76 Kinase Inhibitor 76 Submits NDA 76 Advanced Melanoma 76 Investigational Drug 76 Present Preclinical Data 76 Peginterferon 76 Presents Positive 76 Investigational Compound 76 Improves Outcomes 76 Initiates Phase III 76 Monotherapy 76 HCV Protease Inhibitor 76 Anti Tumor Activity 76 Preclinical Data 76 Clinical Trial Evaluating 76 Previously Treated 76 Phase IIb Clinical Trial 76 Receptor Antagonist 76 Treatment Experienced 76 Viral Load 76 Orally Active 76 Initiates Phase II 75 JAK2 Inhibitor 75 Novel Oral 75 Potent Antiviral Activity 75 Oral Fingolimod 75 Successfully Completes Phase 75 Demonstrates Efficacy 75 Antiviral Activity 75 Pooled Analysis 75 Monoclonal Antibody 75 Protease Inhibitors 75 Receptor Agonist 75 Completes Enrollment 75 Phase 2a Trial 75 Adjunctive Therapy 75 Patients Treated With 75 Antitumor Activity 75 Drug Shows Promise 75 Phase III Trial 75 Phase 2a Clinical Trial 75 Is Well Tolerated 74 Dose Escalation 74 Vaccine Adjuvant 74 Treatment Naive Patients 74 Shows Promise Against 74 Improves Survival 74 Hsp# Inhibitor 74 Patients Receiving 74 Demonstrated Significant 74 HCV Genotype 74 Treating Chronic 74 Polymerase Inhibitor 74 Appears Safe 74 Pivotal Phase 74 Adjuvant Treatment 74 FDA Accepts 74 Rotavirus Vaccine 74 Trial Evaluating 74 Randomized Double Blind 74 Initiates Phase 74 Fungal Infections 74 Shows Efficacy 74 Novel Inhibitor 74 Phase 2b Study 74 IND Application 74 First Patient Dosed 74 Hepatitis C Genotype 74 Parathyroid Hormone 74 Treated Patients 74 Fast Track Status 74 Presents Preclinical 73 Demonstrates Positive 73 Treatment Regimen 73 Peginterferon Alfa 2a 73 Controlled Trial 73 Pharmacokinetic Study 73 Transdermal Patch 73 Phase III Trials 73 RNAi Therapeutic 73 Inflammatory Arthritis 73 Osteoporosis Treatment 73 Initiates Enrollment 73 Severe Sepsis 73 Recombinant Human 73 Infected Patients 73 Initiate Clinical Trial 73 Antitumor 73 Chronic Hepatitis B 73 Investigational Treatment 73 Gout Drug 73 Files IND 73 Mouse Model 73 Novel Mechanism 73 Disease Progression 73 Study Demonstrates 73 Phase Ib Clinical Trial 73 Seasonal Influenza Vaccine 73 Data Suggest 73 Patients Treated 73 Novel Compound 73 Receives Approvable Letter 73 Newly Diagnosed Multiple Myeloma 73 Treatment Reduces 73 Complicated Skin 73 Hospital Acquired Pneumonia 73 Patient Enrollment 73 Cholesterol Lowering Drug 73 Adjuvant Therapy 73 Pharmacokinetics PK 73 Achieves Primary Endpoint 73 Inflammatory Markers 73 Lung Cancer Drug 73 PRN FDA Approves 73 Novel Antibiotic 73 Mylan Receives Approval 73 Significantly Reduces 73 Randomized Phase 73 Systemic Delivery 72 Low Dose 72 Pivotal Phase III 72 Phase 1b Clinical Trial 72 Blood Pressure Drug 72 Inhibits 72 JAK Inhibitor 72 Dose Ranging Study 72 Vicriviroc 72 Nicotine Vaccine 72 Hormone Refractory Prostate Cancer 72 Epilepsy Drug 72 Novel Therapeutic 72 Granted Orphan Drug 72 Long Term Efficacy 72 Improved Survival 72 Shows Promising 72 Relapsing Multiple Sclerosis 72 Therapeutic Vaccine 72 Study Showed 72 Therapeutic Antibody 72 Tiotropium 72 Placebo Controlled Trial 72 Hematological Cancers 72 Hematological Malignancies 72 NDA Submission 72 Potent Inhibitor 72 Viral Suppression 72 Well Tolerated 72 Investigational Oral 72 Pivotal Study 72 Vitro Activity 72 Efficacy Trial 72 Reduces Risk 72 Demonstrates Sustained 72 Immunomodulatory 72 Hepatitis B Virus 72 Reports Preclinical Data 72 Anti Inflammatory 72 Naive Patients 72 Glatiramer Acetate 72 Metastatic Melanoma 72 See CLINICAL PHARMACOLOGY 72 Commences Phase 72 Improve Survival 72 Tyrosine Kinase Inhibitor 72 HDAC Inhibitor 72 Lung Cancer Trial 72 ritonavir boosted 72 Significantly Improved 72 Non Responders 72 FDA Clears 72 Rheumatoid Arthritis Drug 72 Immune Responses 72 Inhaled Corticosteroids 72 Pulmonary Arterial Hypertension 72 Advanced Pancreatic Cancer 72 Proves Effective 72 Drug Resistant 72 Antiangiogenic 72 Ozarelix 72 Placebo Controlled Study 72 Disease Modifying 72 Study Shows Promise 72 Newly Diagnosed 72 Presents Positive Preclinical 72 Relapsed Refractory 72 Demonstrates Potential 72 Receives Milestone Payment 71 Antifungal 71 Postmenopausal Osteoporosis 71 FDA Okays 71 Combo Therapy 71 Versus Placebo 71 Tipranavir 71 Antiviral Therapy 71 Drug Fails 71 Attenuates 71 Anticancer Activity 71 Metastatic Colorectal Cancer 71 Double Blind Randomized 71 FDA Approvals 71 Advanced Renal Cell 71 Osteoporosis Drug 71 Rheumatoid Arthritis Patients 71 Investigational Agent 71 Bosutinib 71 Immunotherapeutic 71 Melphalan 71 Mg Usa 71 Desvenlafaxine Succinate 71 Test Detects 71 Adjuvant Chemotherapy 71 Regimens 71 Vaccine Candidate 71 Proven Effective 71 Slow Progression 71 Interferon Beta 71 Advanced Prostate Cancer 71 Breast Cancer Recurrence 71 Diabetic Neuropathy 71 Randomized Phase II 71 Previously Untreated 71 Hormone Receptor Positive 71 Begin Clinical Trials 71 Virus Infection 71 Prospective Randomized 71 Unfractionated Heparin 71 Epidermal Growth Factor Receptor 71 Oral Cladribine 71 AnaSpec Introduces 71 Prostate Cancer Vaccine 71 Shown Effective 71 Clinical Efficacy 71 Treatment Naive 71 Medoxomil 71 Effectively Treats 71 Subtypes 71 Elderly Patients 71 Metastatic Prostate Cancer 71 Nucleoside 71 Aurora Kinase 71 Renal Cell Carcinoma 71 Small Molecule 71 Drug Combo 71 Tablet Formulation 71 Smallpox Vaccine 71 Predict Response 71 Psoriasis Drug 71 Castration Resistant Prostate Cancer 71 Treatment Resistant 71 Synthetic Peptide 71 ALN HPN 71 Diabetic Foot Ulcer 71 Respiratory Virus 71 Kinase Inhibitors 71 Aliskiren 71 Controlled Study 71 Significantly Improves 71 Initiate Phase III 70 Receives Orphan Drug 70 Kidney Function 70 Survival Benefit 70 Teva Provides Update 70 Myelodysplastic Syndromes 70 IND Filing 70 Receives Fast Track 70 Receptor Antagonists 70 Reduced Risk 70 Clinical Evaluation 70 Initiates Phase 2b 70 TO AVOID PREGNANCY WHILE 70 Sirolimus Eluting Stent 70 Invasive Fungal Infections 70 Shows Promise 70 Confirmatory Phase 70 Plaque Psoriasis 70 II Clinical Trial 70 Migraine Drug 70 Anticoagulant 70 Protein Involved 70 Successfully Treated 70 Cutaneous T 70 Maribavir 70 Hypertensive Patients 70 Hypercholesterolemia 70 Antiplatelet 70 Inhaled Liposomal Ciprofloxacin 70 Capecitabine 70 Febuxostat 70 Collaborators Present 70 Expanded Indication 70 FDA APPROVES 70 Submits Biologics License Application 70 Vaccine Protects Against 70 Anticancer Drug 70 Crit Rev 70 Prodrug 70 Decitabine 70 Osteoarthritis Patients 70 Gastric Cancer 70 Oral Calcitonin 70 Drug Regimen 70 Ranolazine 70 Nilotinib 70 RNAi Therapeutics 70 Anticancer Agent 70 Hepatitis B Vaccine 70 Multiple Ascending Dose 70 Human Monoclonal Antibody 70 Antiviral Drugs 70 Arthritis Drug 70 Pivotal Trials 70 Double Blind Placebo 70 Patients Suffering 70 alfa 2a 70 Patent Covering 70 Demonstrates Statistically Significant 70 Phase III Clinical Trials 70 Dose Ranging 70 Receives Complete Response 70 Telaprevir VX 70 Receives Positive Opinion 70 Oral Mucositis 70 Plus Ribavirin 70 Schizophrenia Treatment 70 Pafuramidine 70 Valopicitabine 70 Clinical Outcome 70 Files Investigational 70 Initiates Clinical Trials 70 Adjuvanted 70 Extended Release 70 Oral Insulin 70 Preclinical Models 70 Statistically Significant 70 2 methoxyestradiol 70 Cardiotoxicity 70 Taxane 70 Vaginal Gel 70 COPEGUS R 70 Clostridium difficile Infection 70 Tolerability 70 Kidney Transplant Patients 70 Study Shows Benefits 70 Immunomedics Announces 70 Cholesterol Drug 70 Insulin Glargine 70 Malaria Vaccine 70 Etravirine 70 Hepatitis C Virus 70 Pediatric Patients 70 Announces Tentative Approval 69 Schizophrenia Drug 69 Lowers Risk 69 Hepatitis C Patients 69 Dose Response 69 MEK Inhibitor 69 Earns Milestone Payment 69 Prostate Cancer Patients 69 Secondary Hyperparathyroidism 69 Sapacitabine 69 Soft Tissue Sarcoma 69 Gene Variant 69 Begins Dosing 69 Clinical Trial Data 69 Interferon beta 1a 69 Clinical Study Shows 69 Subgroup Analysis 69 Tezampanel 69 Inhaled Insulin 69 Fracture Risk 69 Vascular Inflammation 69 Posaconazole 69 Preclinical Study 69 Boceprevir 69 Interferon Alpha 69 non nucleoside inhibitor 69 Neoadjuvant Chemotherapy 69 Significantly Reduced 69 Therapeutic Efficacy 69 Oncolytic 69 Mg Uk 69 Signaling Pathway 69 Chemoradiation 69 Protein Linked 69 Gene Linked 69 Diabetic Patients 69 Guidelines Issued 69 Randomized Clinical Trial 69 Pegylated Interferon 69 Histone Deacetylase 69 Allogeneic 69 Epratuzumab 69 Pivotal Trial 69 Meta Analysis 69 nucleotide analog 69 Antibody Drug Conjugate 69 Entry Inhibitor 69 Develop Novel 69 Glufosfamide 69 Genes Involved 69 Hepatic Encephalopathy 69 Late Breaker 69 Autologous Stem Cell Transplantation 69 Capsules CII 69 Transdermal Delivery 69 Knee Osteoarthritis 69 Cinacalcet 69 oral prodrug 69 Cyclophosphamide 69 Panzem R 69 FDA Approves Drug 69 Pneumococcal Vaccine 69 Milestone Payment 69 Fixed Dose 69 Vaccine Shows Promise 69 Chemotherapeutic Agents 69 Migraine Treatment 69 SPRYCEL ® 69 Prophylactic Treatment 69 Fludarabine 69 Fondaparinux 69 Anticancer Compound 69 Blinatumomab 69 Interferon Gamma 69 Antigen Specific 69 Randomized Clinical Trials 69 Efficacious 69 Generic Version 69 Shingles Vaccine 69 First Patient Enrolled 69 Avian Flu Vaccine 69 Phospholipase A2 69 Anthracycline 69 FDA Approves 69 R lenalidomide 69 Randomized Double Blind Placebo 69 Unresectable 69 Recommends Approval 69 Factor Receptor 69 Submits Supplemental 69 Sustiva efavirenz 69 Initiates Dosing 69 Angiotensin Converting Enzyme 69 Anti Inflammatory Drug 69 refractory chronic lymphocytic 69 ACE Inhibitors 69 Dendritic Cells 69 Elagolix 69 Showed Significant 69 Beneficial Effects 69 Commence Phase 69 Transplant Patients 69 Lymphocytic 69 Confirms Efficacy 69 Atypical Antipsychotic 69 Announces Initiation 69 Chemotherapy Induced 69 Treat Anemia 69 Refractory Hodgkin Lymphoma 69 Estrogen Therapy 69 Pandemic Flu Vaccine 69 Multiple Myeloma Patients 69 HER2 Positive 69 Fixed Dose Combination 68 Phase III Pivotal 68 Rigel R# 68 HCV RNA polymerase 68 Hepatitis C Treatment 68 Experimental Vaccine 68 Pandemic Influenza Vaccine 68 Study Reinforces 68 sunitinib Sutent ® 68 Generic Versions 68 Demonstrates Ability 68 Combination REOLYSIN R 68 Phase 2a Study 68 Anti CD# Antibody 68 miconazole Lauriad ® 68 Stem Cell Transplants 68 Tumor Growth 68 Dasatinib 68 Relapsing Remitting Multiple Sclerosis 68 Therapeutic Potential 68 Therapy Improves 68 Inhibitor 68 Randomized Trials 68 Darunavir 68 GW# [003] 68 abacavir sulfate lamivudine 68 brivanib 68 Fewer Side Effects 68 Immunosuppressant 68 novel emulsion formulation 68 Renal Function 68 Brentuximab Vedotin SGN 68 Lubiprostone 68 Statin Drugs 68 Thiovir 68 Therapeutic Vaccines 68 Cardiac Function 68 CYP#A# CYP#D# 68 Hepatocellular Carcinoma 68 Daptomycin 68 Bazedoxifene 68 Gene Mutation 68 Pharmaceuticals Initiates 68 Septic Shock 68 Diabetic Nephropathy 68 Submits IND 68 Antipsychotic Drugs 68 Topical Treatment 68 Postmenopausal Women 68 Colorectal Cancer Patients 68 ABLYNX 68 erlotinib Tarceva ® 68 Levels Linked 68 Develops Novel 68 Advanced Colorectal Cancer 68 Nitazoxanide 68 Node Positive 68 Angiogenic 68 Mimetics 68 Lowers Blood Pressure 68 Anemia Drug 68 Granulocyte Colony Stimulating Factor 68 Myeloma Patients 68 Shows Statistically Significant 68 Saquinavir 68 Trandolapril 68 Pegylated Liposomal Doxorubicin 68 TB Vaccine 68 Lupus Nephritis 68 Benign Prostatic Hyperplasia 68 Asthma Treatment 68 Follicular Lymphoma 68 Heart Failure Patients 68 Guidelines Recommend 68 Osteoporosis Drugs 68 Cholesterol Lowering 68 Inhaled Nitric Oxide 68 By JENNIFER LEARN 68 Topline Results 68 Randomized Study 68 Antidepressant Drug 68 Cholinesterase Inhibitors 68 Chemotherapy Improves 68 Potentially Fatal 68 Treatment Naïve Patients 68 Patient Enrolment 68 Immune Cells 68 BioSante Pharmaceuticals Announces 68 Ovarian Cancer Patients 68 Immunosuppression 68 Acute Ischemic Stroke 68 Cethromycin 68 Relapsed Multiple Myeloma 68 Insulin Resistance 68 Demonstrate Significant 68 Tigecycline 68 Improve Outcomes 68 Metabolic Disorder 68 J Allergy Clin 68 IN PATIENTS WITH 68 Novel Anti Inflammatory 68 Cholesterol Drugs 68 Neoadjuvant 68 Patients Undergoing 68 Denufosol 68 Anti Clotting Drug 68 Inflammatory Disease 68 Intranasal 68 Blood Thinner 68 Immune Cell 68 Tumor Suppressor 68 Randomized Double blind 68 Sandostatin R 68 Universal Flu Vaccine 68 Statin Therapy 68 abacavir Ziagen 68 investigational oral inhibitor 68 Peginterferon alfa 2b 68 Biomarker Study 68 Antiretroviral Therapy 68 Dengue Virus 68 Sustained Virologic Response 68 Targeted Therapy 68 Spectrum Pharmaceuticals Announces 68 Antiplatelet Therapy 68 Hemodialysis Patients 68 Irinotecan 68 Cell Transplants 68 Peginterferon Alfa 2b 68 Percutaneous Tibial Nerve Stimulation 68 Progenitor Cells 68 Crofelemer budesonide foam 68 Serious Infections 68 Erectile Dysfunction Drug 68 Contrast Agents 68 Sustained Release 68 HIV Integrase Inhibitor 68 Reductase 68 Community Acquired Pneumonia 68 Slows Progression 68 Demonstrates Long Term 68 Anti Angiogenic 68 #mg/#mg 68 Drug Prevents 68 Adefovir 68 Atripla combines 68 Mycophenolate Mofetil 68 Subtype 68 3TC lamivudine 68 Estrogen Receptor 68 tenofovir disoproxil fumarate Viread 68 dasatinib Sprycel ® 68 Genes Linked 68 Tuberculosis Vaccine 68 Venous Thromboembolism 68 Minimally Invasive Treatment 68 Obese Patients 67 Interferon Alfa 67 Oral Formulation 67 Pneumococcal Conjugate Vaccine 67 Tumor Targeting 67 Anti Angiogenesis 67 Collaborators Publish 67 Renal Impairment 67 Metastatic Renal Cell Carcinoma 67 Epoetin 67 Cites Positive 67 Voreloxin 67 Oral Laquinimod 67 Resubmission 67 Platelet Function 67 Lenalidomide 67 Oral Spray 67 Resistant Hypertension 67 Protein Expression 67 Vaccine Adjuvants 67 Cellular Immunotherapy 67 Immunogenicity 67 Combination Clinical Trial 67 Abstract Accepted 67 Advanced Ovarian Cancer 67 Bronchodilator 67 Partial Seizures 67 Acute Heart Failure 67 Vildagliptin 67 Ecallantide 67 Therapeutic Competitors Companies 67 Radiation Induced 67 Pramlintide 67 Romidepsin 67 Enlarged Prostate 67 Influenza Vaccine Production 67 Lung Injury 67 Brain Metastases 67 Ibritumomab Tiuxetan 67 2 inhibitor CYT# 67 Multiple Dose 67 Genotypes 67 Protein Interactions 67 Quadrivalent 67 RELOVAIR ™ 67 Gastrointestinal Disorders 67 Kidney Transplant Recipients 67 Chronic Lymphocytic Leukemia CLL 67 Non Invasive Treatment 67 Announces Poster Presentations 67 Camptosar ® 67 Cytochrome P# 67 pan histone deacetylase 67 Submits Investigational 67 5 Fluorouracil 67 Hemorrhagic Stroke 67 Systemic Sclerosis 67 Artery Disease 67 Randomized Controlled Trials 67 Blood Pressure Drugs 67 BiTE Antibody 67 Seasonal Influenza 67 Intravenous Formulation 67 Dry Powder Inhalers 67 Cardiovascular Events 67 Valproic Acid 67 Prophylaxis 67 Ebola Vaccine 67 Receives FDA Clearance 67 Biologic Therapy 67 Gets FDA Clearance 67 Symptom Relief 67 Tumor Necrosis Factor 67 azilsartan medoxomil 67 Systematic Review 67 Dehydrogenase 67 Left Ventricular 67 nucleoside analog 67 Disease Modification 67 Protein Synthesis 67 familial amyloidotic polyneuropathy FAP 67 Romiplostim 67 indinavir Crixivan 67 Metabolic Efficiency 67 Neuroendocrine Tumors 67 Million Milestone Payment 67 Sustained Efficacy 67 Effective Than 67 Higher Doses 67 DOXIL R 67 Visceral Fat 67 Bone Metastases 67 Safinamide 67 Chemotherapy Regimen 67 Reduces Pain 67 Lung Cancers 67 Diamyd Medical Diamyd 67 Recurrent Breast Cancer 67 Chronic Renal Failure 67 Pegylated 67 Metformin HCl 67 Chemokine Receptor 67 Laryngeal Cancer 67 Lipid Lowering 67 Diabetic Neuropathic Pain 67 NICE Recommends 67 Inflammatory Diseases 67 PKC# 67 Myelodysplastic Syndrome MDS 67 Smooth Muscle 67 Partial Onset Seizures 67 Antibody Discovery 67 Immune Therapy 67 Janus kinase 67 Calcium Vitamin D 67 Nanoemulsion 67 Submits Application 67 Indacaterol 67 Second Pivotal Phase 67 dasatinib Sprycel 67 Agonist MABA program 67 Randomized Controlled 67 nucleoside reverse transcriptase inhibitor 67 Pharmacodynamics 67 Completes Dosing 67 evaluating mipomersen 67 Lung Cancer Survival 67 PDUFA Date 67 Randomized Controlled Trial 67 Pneumonia Vaccine 67 oral renin inhibitor 67 Bipolar Depression 67 Vaccine Prevents 67 Metabolic Disease 67 Preterm Delivery 67 Allergic Rhinitis 67 Susceptibility Testing 67 Tesamorelin 67 Protease 67 Testosterone Gel 67 AVI BioPharma Announces 67 Helps Predict 67 Ridaforolimus 67 FOLOTYN ® 67 Announces Presentation 67 ara C 67 Liposomal 67 Novel Method 67 Overactive Bladder 67 siRNA Delivery 67 Prevent Stroke 67 CYT# potent vascular disrupting 67 Proteasome 67 Patients Enrolled 67 Tumor Cell 67 vapreotide acetate 67 Genetic Tests 67 TKB# 67 Tumor Response 67 Long Term Outcomes 67 Pegloticase 67 Circulating Tumor Cells 67 Cancer Vaccines 67 Haemophilus b Conjugate 67 Omacetaxine 67 adalimumab Humira 67 Anthrax Vaccine 67 Clinical Outcomes 67 Replacement Therapy 67 Xeloda ® 67 Humanized Anti 67 Weight Loss Drug 67 Initiated Phase 67 Cocaine Addiction 67 Maleate 67 Renal Cell Cancer 67 tenofovir Viread 67 Prolongs Life 67 Inhalation Solution 67 Adenoviral 67 Analogs 67 Left Ventricular Hypertrophy 67 Predict Dementia 67 Atopic Dermatitis 67 Autoimmune Disease 67 Influenza Vaccine 67 Launches Generic Version 67 Medullary Thyroid Cancer 67 polymerase inhibitor 67 evaluating picoplatin 67 Therapy Reduces 67 Chronic Lymphocytic Leukemia 67 Prognostic Factors 66 Receive Milestone Payment 66 Bavituximab 66 Oral Fluid 66 Announce Merger Agreement 66 Integrase 66 Prove Effective 66 Taro Receives 66 novel VDA molecule 66 Predict Risk 66 Genital Herpes 66 Platinol ® 66 Clin Trials 66 Hospitalized Patients 66 Oral Presentations 66 Epoetin Alfa 66 Pfizer Discontinues 66 Pazopanib 66 darunavir Prezista 66 Cloretazine 66 Treatment Adherence 66 Study Evaluates 66 Left Ventricular Dysfunction 66 Menstrual Pain 66 Vitamin D Linked 66 Chronic Myeloid Leukemia 66 AAG geldanamycin analog 66 Tyrosine Kinase Inhibitors 66 relapsed MM 66 Induces 66 Increased Risk 66 Am J Clin 66 Antipsychotic 66 Cannabinoid 66 Diagnostic Tests 66 Treatment Shows Promise 66 Helps Smokers Quit 66 5 FU leucovorin 66 platform HDL Mimetic 66 Prognostic Significance 66 Itraconazole 66 Miconazole 66 Stent Placement 66 dependent kinase inhibitor 66 Advanced Solid Tumors 66 BARACLUDE ® 66 HCV polymerase 66 Watchful Waiting 66 fosbretabulin 66 Pyridorin TM 66 Coadministration 66 Novel Anticancer 66 J Clin 66 Licenses Novel 66 Novel Peptide 66 Hepatitis C Infection 66 Renal Cancer 66 Celgosivir 66 Risk Stratification 66 Issues Guidance 66 Recurrent Glioblastoma 66 Receives Marketing Authorization 66 Zorbtive TM 66 Localized Prostate Cancer 66 Efficacy Results 66 Orthostatic Hypotension 66 Cognitive Impairment 66 Lowering Blood Pressure 66 Chronic Sinusitis 66 Albuferon TM 66 Sevelamer 66 Heart Transplant Recipients 66 ® lenalidomide 66 Juvenile Idiopathic Arthritis 66 ARIXTRA R 66 Critically Ill Patients 66 developing Bicifadine serotonin 66 Modulates 66 pralatrexate injection folate analogue 66 Menopausal Women 66 orally administered inhibitor 66 Antiretroviral 66 Breast Cancer Patients 66 Novel Vaccine 66 Approvable 66 Enoxaparin 66 Newly Identified 66 Antiepileptic Drug 66 FDA Panel Recommends 66 Hormone Therapy 66 Announces FDA Clearance 66 Clinical Study 66 Boosts Survival 66 Idenix Novartis 66 PEGylated anti 66 Metastatic Pancreatic Cancer 66 Antiviral Agents 66 Antidepressants Linked 66 Premenopausal Women 66 thalidomide Thalomid 66 Aptamer 66 Increases Risk 66 Natalizumab 66 beta 1a 66 Eluting Stent 66 Refractory Angina 66 Adverse Event 66 Retinal Vein Occlusion 66 Submits Response 66 Transdermal System 66 Endovascular Treatment 66 Autoimmune Diseases 66 Hedgehog Pathway 66 Lymphoid 66 Therapeutic Competitors Report 66 Dose Finding 66 Small Molecule Inhibitors 66 Non Alcoholic Steatohepatitis 66 Blood Pressure Medication 66 amprenavir 66 REYATAZ ® 66 Therapeutic Targets 66 Therapy Shows Promise 66 Prospective Multicenter 66 Conjugate Vaccine 66 Holds Promise 66 COLLABORATION WITH 66 Inflammatory Pain 66 Zoledronic Acid 66 non peptidic protease 66 Gene Variants 66 Cell Adhesion 66 Moxifloxacin 66 Breast Tumors 66 LymphoStat B TM 66 metastatic malignant 66 Tesetaxel 66 HER2 Positive Breast Cancer 66 Prognostic Value 66 Myocardial Ischemia 66 Preclinical Studies 66 Polymorphisms 66 Deforolimus 66 Eszopiclone 66 Significant Efficacy 66 Epilepsy Drugs 66 lamivudine zidovudine 66 topical gel formulation 66 Viral Infections 66 Neutralizing Antibodies 66 Skeletal Muscle 66 Antiviral Drug 66 Sleep Disturbances 66 Live Attenuated 66 Lipid Levels 66 Aflibercept 66 Cardiovascular Disease Risk 66 Liver Metastases 66 lexidronam injection 66 Tyrosine Kinase 66 ISTODAX ® 66 Antithrombin